Moreover, we observed a significant increase in ATAD3A immunodensity in neurons immunopositive for anti-NeuN antibodies in the postmortem cortex of AD patients compared to normal subjects (Fig. 1g). Here, RBFOX3 is linked to Alzheimer disease.